Some areas of are temporarily unavailable. We apologize for the inconvenience and are working to restore access.

  • BusinessWire

    The U.S. FDA has approved a generic equivalent of Cosopt.

    Lannett Company reports that its Abbreviated New Drug Application was approved for dorzolamide hydrochloride and timolol maleate ophthalmic solution, 2%/0.5% for patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.